Moïse Namer

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Aron Goldhirsch, Eric P. Winer, Alan S. Coates et al. · Annals of Oncology · 2013 · 3.7K citations · Full text

Medicine, Oncology, Breast Oncology +10

Breast Cancer With Synchronous Metastases: Trends in Survival During a 14-Year Period

Fabrice André, Khémaies Slimane, Thomas Bachelot et al. · Journal of Clinical Oncology · 2004 · 396 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Epirubicin Increases Long-Term Survival in Adjuvant Chemotherapy of Patients With Poor-Prognosis, Node-Positive, Early Breast Cancer: 10-Year Follow-Up Results of the French Adjuvant Study Group 05 Randomized Trial

Jacques Bonneterre, Henri Roché, Pierre Kerbrat et al. · Journal of Clinical Oncology · 2005 · 274 citations · Full text

Medicine, Oncology, Pharmacology +17

CLINICAL AND PHARMACOKINETIC EVIDENCE OF A LIFE-THREATENING INTERACTION BETWEEN METHOTREXATE AND KETOPROFEN

A. Thyss, Johanna Kubar, G. Milano et al. · The Lancet · 1986 · 252 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Randomized Parallel Study of Doxorubicin Plus Paclitaxel and Doxorubicin Plus Cyclophosphamide As Neoadjuvant Treatment of Patients With Breast Cancer

Véronique Dièras, P. Fumoleau, Gilles Romieu et al. · Journal of Clinical Oncology · 2004 · 155 citations

Medicine, Oncology, Pharmacology +16